The Efficacy of Exergaming in People With Major Neurocognitive Disorder Residing in Long-term Care Facilities: A Randomized Controlled Trial

Davy Vancampfort1 site in 1 country50 target enrollmentJanuary 2, 2019

ConditionsRandomised Controlled Trial Major Neurocognitive Disorder Long-term Care Facility Physical Activity Cognitive Impairment

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Randomised Controlled Trial
Sponsor: Davy Vancampfort
Enrollment: 50
Locations: 1
Primary Endpoint: NPI
Last Updated: 5 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This randomized controlled trial explores the efficacy of an 8-week standing exergaming program in people with major neurocognitive disorder (MNCD) residing in long-term care facilities.

Detailed Description

This randomized controlled trial explores the efficacy of an 8-week standing exergaming program in people with major neurocognitive disorder (MNCD) residing in long-term care facilities. Fifty inpatients with mild to moderate MNCD will be randomly assigned to three times weekly for eight weeks 15 min of exergaming versus watching preferred music videos. The Montréal Cognitive Assessment (MoCA), Short Physical Performance Battery (SPPB), Neuropsychiatric Inventory (NPI), Cornell Scale for Depression in Dementia (CSDD), Dementia Quality of Life (DQoL), Katz activities of daily living (ADL) and Instrumental ADL (IADL) are measured at baseline and post intervention.

Registry

clinicaltrials.gov

Start Date

January 2, 2019

End Date

September 30, 2020

Last Updated

5 years ago

Study Type

Interventional

Study Design

Sequential